These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 20882771)

  • 1. [Development of pulmonary chlamydia infection in inbred mice lines differentiated by genetically determinated sensitivity to tuberculosis infection].
    Nesterenko LN; Aliapkina IuS; Pashko IuP; Kondrat'eva EV; Kapina MA; Balunets DV; Zagangirova NA; Romanova IuM; Apt AS
    Mol Gen Mikrobiol Virusol; 2010; (3):12-6. PubMed ID: 20882771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium tuberculosis-susceptible I/St mice develop severe disease following infection with taxonomically distant bacteria, Salmonella enterica and Chlamydia pneumoniae.
    Nesterenko LN; Balunets DV; Tomova AS; Romanova JM; Alyapkina JS; Zigangirova NA; Kapina MA; Kondratieva EV; Pichugin AV; Majorov KB; Apt AS
    Clin Exp Immunol; 2006 Oct; 146(1):93-100. PubMed ID: 16968403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. I/St mice hypersusceptible to Mycobacterium tuberculosis are resistant to M. avium.
    Kondratieva EV; Evstifeev VV; Kondratieva TK; Petrovskaya SN; Pichugin AV; Rubakova EI; Averbakh MM; Apt AS
    Infect Immun; 2007 Oct; 75(10):4762-8. PubMed ID: 17664269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12 administered during Chlamydia psittaci lung infection in mice confers immediate and long-term protection and reduces macrophage inflammatory protein-2 level and neutrophil infiltration in lung tissue.
    Huang J; Wang MD; Lenz S; Gao D; Kaltenboeck B
    J Immunol; 1999 Feb; 162(4):2217-26. PubMed ID: 9973497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice.
    Radaeva TV; Nikonenko BV; Mischenko VV; Averbakh MM; Apt AS
    Tuberculosis (Edinb); 2005; 85(1-2):65-72. PubMed ID: 15687029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A human-like TB in genetically susceptible mice followed by the true dormancy in a Cornell-like model.
    Radaeva TV; Kondratieva EV; Sosunov VV; Majorov KB; Apt A
    Tuberculosis (Edinb); 2008 Nov; 88(6):576-85. PubMed ID: 18667358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlamydia pneumoniae infection in IL-10 knock out mice: accelerated clearance but severe pulmonary inflammatory response.
    Penttilä T; Haveri A; Tammiruusu A; Vuola JM; Lahesmaa R; Puolakkainen M
    Microb Pathog; 2008 Jul; 45(1):25-9. PubMed ID: 18456450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis of Chlamydia pneumoniae-type pneumonitis in mice.
    Shi Y; Yin J; Zhan H; Feng G; Zhang X; Su X; Song Y; Xia X; Zhou X; Shen P
    Chin Med J (Engl); 2003 Mar; 116(3):328-32. PubMed ID: 12781030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.
    Mohler J; Moine P; Azoulay-Dupuis E; Henin D; Fantin B
    Eur Cytokine Netw; 2007 Mar; 18(1):23-30. PubMed ID: 17400535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential involvement of TLR2 and TLR4 in host survival during pulmonary infection with Chlamydia pneumoniae.
    Rodriguez N; Wantia N; Fend F; Dürr S; Wagner H; Miethke T
    Eur J Immunol; 2006 May; 36(5):1145-55. PubMed ID: 16609927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment and experimental study on mouse model of Chlamydia pneumoniae pneumonitis].
    Shi Y; Yin J; Zhan H
    Zhonghua Jie He He Hu Xi Za Zhi; 2001 Oct; 24(10):592-5. PubMed ID: 11770419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sst1 resistance locus regulates evasion of type I interferon signaling by Chlamydia pneumoniae as a disease tolerance mechanism.
    He X; Berland R; Mekasha S; Christensen TG; Alroy J; Kramnik I; Ingalls RR
    PLoS Pathog; 2013; 9(8):e1003569. PubMed ID: 24009502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Chlamydia pneumoniae reinfection accelerates the development of insulin resistance and diabetes in obese C57BL/6 mice.
    Wang C; Gao D; Kaltenboeck B
    J Infect Dis; 2009 Jul; 200(2):279-87. PubMed ID: 19508161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intragastric primary infection sensitizes to lung reinfection in a Chlamydia pneumoniae mouse model.
    Erkkilä L; Saario E; Laitinen K; Saikku P; Leinonen M
    Vaccine; 2008 May; 26(20):2503-9. PubMed ID: 18433949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the lung transcriptome in Mycobacterium tuberculosis-infected mice reveals major differences in immune response pathways between TB-susceptible and resistant hosts.
    Shepelkova G; Pommerenke C; Alberts R; Geffers R; Evstifeev V; Apt A; Schughart K; Wilk E
    Tuberculosis (Edinb); 2013 Mar; 93(2):263-9. PubMed ID: 23276693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection.
    Yang X; Brunham RC
    J Immunol; 1998 Aug; 161(3):1439-46. PubMed ID: 9686609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Nickel Sulfate Hexahydrate (CAS No. 10101-97-0) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Jul; 454():1-380. PubMed ID: 12587012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new model for chronic and reactivation tuberculosis: Infection with genetically attenuated Mycobacterium tuberculosis in mice with polar susceptibility.
    Kondratieva TK; Kapina MA; Rubakova EI; Kondratieva EV; Nikonenko BV; Majorov KB; Dyatlov AV; Linge IA; Apt AS
    Tuberculosis (Edinb); 2018 Dec; 113():130-138. PubMed ID: 30514495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of susceptibility to pulmonary infection with Chlamydia pneumoniae in the mouse.
    Min-Oo G; Lindqvist L; Vaglenov A; Wang C; Fortin P; Li Y; Kaltenboeck B; Gros P
    Genes Immun; 2008 Jun; 9(4):383-8. PubMed ID: 18075514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.